Clinical Trial Update: Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma [Phase 2]

View source ↗

Summary

This Phase 2 trial comparing cetuximab with radiation versus surgery around radiation for colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: American Scitech International | Conditions: Colorectal Carcinoma | Phase 2 | Status: WITHDRAWN